Yong-hong Zhu

No. 74, Zhongshan Road 2
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Bromocriptine sensitivity in bromocriptine-induced drug-resistant prolactinomas is restored by inhibiting FGF19/FGFR4/PRL.

Bromocriptine sensitivity in bromocriptine-induced drug-resistant prolactinomas is restored by inhibiting FGF19/FGFR4/PRL.

Journal: Journal of endocrinological investigation

Published: December 15, 2023

Clinical application of combination [11C]C-methionine and [13N]N-ammonia PET/CT in recurrent functional pituitary adenomas with negative MRI or [18F]F-FDG PET/CT.

Clinical application of combination [11C]C-methionine and [13N]N-ammonia PET/CT in recurrent functional pituitary adenomas with negative MRI or [18F]F-FDG PET/CT.

Journal: BMC endocrine disorders

Published: June 29, 2023

CircOMA1 modulates cabergoline resistance by downregulating ferroptosis in prolactinoma.

CircOMA1 modulates cabergoline resistance by downregulating ferroptosis in prolactinoma.

Journal: Journal of endocrinological investigation

Published: September 04, 2022

Predictors of postoperative biochemical remission in lower Knosp grade growth hormone-secreting pituitary adenomas: a large single center study.

Predictors of postoperative biochemical remission in lower Knosp grade growth hormone-secreting pituitary adenomas: a large single center study.

Journal: Journal of endocrinological investigation

Published: March 24, 2022

Predictors of postoperative biochemical remission in acromegaly.

Predictors of postoperative biochemical remission in acromegaly.

Journal: Journal of neuro-oncology

Published: September 29, 2020

Common tools for pituitary adenomas research: cell lines and primary cells.

Common tools for pituitary adenomas research: cell lines and primary cells.

Journal: Pituitary

Published: November 16, 2019

MiR-1299 promotes the synthesis and secretion of prolactin by inhibiting FOXO1 expression in drug-resistant prolactinomas.

MiR-1299 promotes the synthesis and secretion of prolactin by inhibiting FOXO1 expression in drug-resistant prolactinomas.

Journal: Biochemical and biophysical research communications

Published: September 05, 2019

miR-93-5p targets Smad7 to regulate the transforming growth factor-β1/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma.

miR-93-5p targets Smad7 to regulate the transforming growth factor-β1/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma.

Journal: Brain research bulletin

Published: December 26, 2018

Role of TGF-β1/Smad3-mediated fibrosis in drug resistance mechanism of prolactinoma.

Role of TGF-β1/Smad3-mediated fibrosis in drug resistance mechanism of prolactinoma.

Journal: Brain research

Published: March 30, 2018

Utility of 13N-Ammonia PET/CT to Detect Pituitary Tissue in Patients with Pituitary Adenomas.

Utility of 13N-Ammonia PET/CT to Detect Pituitary Tissue in Patients with Pituitary Adenomas.

Journal: Academic radiology

Published: March 11, 2018

MicroRNAs and Target Genes in Pituitary Adenomas.

MicroRNAs and Target Genes in Pituitary Adenomas.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Published: March 10, 2018

Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1.

Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1.

Journal: Journal of endocrinological investigation

Published: January 23, 2018

Showing 1-12 of 24

Last Updated: 09/26/2026